Antenatal diagnosis of severe combined immunodeficiency from fetal cord blood

[Extracorporeal membrane oxygenation in critically ill neonates and children].

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2017

Hyper-immunoglobulin M syndrome type 3 with normal CD40 cell surface expression.

Scandinavian journal of immunology·2012

Immunoglobulin class switch recombination deficiencies.

Clinical immunology (Orlando, Fla.)·2010

Intravenous immunoglobulins--understanding properties and mechanisms.

Clinical and experimental immunology·2009

6th International Immunoglobulin Symposium: poster presentations.

Clinical and experimental immunology·2009

Isolated growth hormone deficiency in a patient with immunoglobulin class switch recombination deficiency.

Journal of investigational allergology & clinical immunology·2009

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Lancet (London, England)·2026

Incidental Detection of Atrial Myxoma in Early Infancy: A Rare Case Report.

World journal for pediatric & congenital heart surgery·2026

Shelf-life of cord blood red cell concentrates: Comparison of two additive solutions.

Transfusion·2026

The effect of umbilical venous catheterization on splanchnic oxygenation in preterm infants: A prospective cohort study.

Journal of pediatric gastroenterology and nutrition·2026

Commutability assessment of candidate reference materials for total bilirubin assays in neonates.

Clinical chemistry and laboratory medicine·2026

Case Report: Prenatal diagnosis of congenital knee dislocation caused by BICD2 gene variant.

Frontiers in genetics·2026

Gastric teratoma presenting as gastrointestinal bleeding in a neonate: a case report and review of literature.

Journal of surgical case reports·2026

Related Experiment Videos

Antenatal diagnosis of severe combined immunodeficiency from fetal cord blood

Related Concept Videos

[Extracorporeal membrane oxygenation in critically ill neonates and children].

Hyper-immunoglobulin M syndrome type 3 with normal CD40 cell surface expression.

Immunoglobulin class switch recombination deficiencies.

Intravenous immunoglobulins--understanding properties and mechanisms.

6th International Immunoglobulin Symposium: poster presentations.

Isolated growth hormone deficiency in a patient with immunoglobulin class switch recombination deficiency.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

14-day versus 28-day trifluridine-tipiracil plus bevacizumab for refractory metastatic colorectal cancer (PRABITAS): a pragmatic, multicentre, open-label, randomised, phase 3, non-inferiority trial in Japan.

Incidental Detection of Atrial Myxoma in Early Infancy: A Rare Case Report.

Shelf-life of cord blood red cell concentrates: Comparison of two additive solutions.

The effect of umbilical venous catheterization on splanchnic oxygenation in preterm infants: A prospective cohort study.

Commutability assessment of candidate reference materials for total bilirubin assays in neonates.

Case Report: Prenatal diagnosis of congenital knee dislocation caused by BICD2 gene variant.

Gastric teratoma presenting as gastrointestinal bleeding in a neonate: a case report and review of literature.

Related Experiment Videos

Antenatal diagnosis of severe combined immunodeficiency from fetal cord blood

Related Concept Videos

Related Articles